These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35366017)
1. Histopathology of persistent long COVID toe: A case report. Nirenberg MS; Requena L; Santonja C; Smith GT; McClain SA J Cutan Pathol; 2022 Sep; 49(9):791-794. PubMed ID: 35366017 [TBL] [Abstract][Full Text] [Related]
2. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection. El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947 [TBL] [Abstract][Full Text] [Related]
3. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741 [TBL] [Abstract][Full Text] [Related]
4. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. Cappel MA; Cappel JA; Wetter DA Mayo Clin Proc; 2021 Apr; 96(4):989-1005. PubMed ID: 33714595 [TBL] [Abstract][Full Text] [Related]
5. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic. Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396 [TBL] [Abstract][Full Text] [Related]
7. Cilostazol as a Treatment for COVID Toes: A Case Report. McClelland P; Gray BH Ann Vasc Surg; 2023 Apr; 91():76-80. PubMed ID: 36442709 [TBL] [Abstract][Full Text] [Related]
8. COVID Purpura (Toes) Case Series: A Chilblains-Like Vasculopathy. Olsen TG; Shrit MA; Feeser TA; Wargo JJ Am J Dermatopathol; 2021 Apr; 43(4):e47-e50. PubMed ID: 33156022 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567 [TBL] [Abstract][Full Text] [Related]
11. COVID toes: where do we stand with the current evidence? Baeck M; Herman A Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530 [TBL] [Abstract][Full Text] [Related]
12. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19. Patrì A; Vargas M; Buonanno P; Annunziata MC; Russo D; Staibano S; Servillo G; Fabbrocini G Diagn Pathol; 2021 Feb; 16(1):16. PubMed ID: 33632250 [TBL] [Abstract][Full Text] [Related]
14. Lack of association between pandemic chilblains and SARS-CoV-2 infection. Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624 [TBL] [Abstract][Full Text] [Related]
15. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic. Massey PR; Jones KM Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881 [TBL] [Abstract][Full Text] [Related]
16. Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic. Sohier P; Matar S; Meritet JF; Laurent-Roussel S; Dupin N; Aractingi S Arch Pathol Lab Med; 2021 Feb; 145(2):137-144. PubMed ID: 33501498 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. Nakashima C; Kato M; Otsuka A J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825 [TBL] [Abstract][Full Text] [Related]
19. Chilblain-like lesions with prominent bullae in a patient with COVID-19. Rubin A; Alamgir M; Rubin J; Rao BK BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373 [TBL] [Abstract][Full Text] [Related]
20. Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19. Gallizzi R; Sutera D; Spagnolo A; Bagnato AM; Cannavò SP; Grasso L; Guarneri C; Nunnari G; Mazza F; Pajno GB Dermatol Ther; 2020 Nov; 33(6):e14312. PubMed ID: 32949449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]